Long-term treatment of Swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin-like growth factor-I (IGF-I)

Cell Biochemistry and Function

Volumn 14, Issue 2, 1996, Pages 121-129

  Hansson, Anders ^a   Hehenberger, Karin ^a   Thorén, Marja ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; STEROID; TETRAZOLIUM;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROBLAST CULTURE; GLYCOGEN SYNTHESIS; IMMUNOBLOTTING; LIPOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS;

ANIMALIA;

EID: 0029884824     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.656     Document Type: Article

References (58)

1. Cushing, H. (1932). The basophil adenomas of the pituitary and their clinical manifestations. Johns Hopkins Hosp. Bull. 50, 137-195.
2. Curtess, H., Clarks, W. S. and Herndon, C. H. (1954). Vertebral fractures resulting from prolonged cortisone and cortisotropin therapy. J. Am. Med. Ass. 156, 467-469.
3. Raisz, L. G. and Kream, B. E. (1983). Regulation of bone formation. N. Engl. J. Med., 309, 29-35.
4. Elgindy, N., Grunditz, R., Thorén, M., Degerblad, M., Sjöberg, H. E. and Ringertz, H. (1991). Long term follow up of metacarpal cortical thickness and bone mineral density in panhypopituitarism. Radio. Diagn., 32, 326-330.
5. Degerblad, M., Elgindy, N., Hall, K., Sjöberg, H. E., and Thorén, M. (1992). Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrin. (Copenh.), 126, 387-393.
6. Hall, K. and Tally, M. (1989). The somatomedin-insulin-like growth factors. J. Intern. Med., 225, 47-54.
7. Shimasaki, S. and Lang, N. (1991). Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog. Growth Factor Res., 3, 243-266.
8. Degerblad, M., Põvoa, G., Thorén, M., Wivall, I. L. and Hall, K. (1989). Lack of diurnal rhythm of low molecular weight insulin-like growth factor binding protein in patients with Cushing's disease. Acta Endocrin. (Copenh.), 120, 195-200.
9. Bang, P., Degerblad, M., Thorén, M., Schwander, J., Blum, W. and Hall, K. (1993). Insulin-like growth factors (IGFs) I and II and IGF binding proteins 1, 2, and 3 in serum from patients with Cushing's syndrome. Acta Endocrin. (Copenh.), 128, 397-404.
10. Bikle, D. D., Harris, J., Halloran, B. P. and Morey-Holton, E. R. (1994). Skeletal unloading induces resistance to insulin-like growth factor I. J. Bone Min. Res., 9, 1789-1796.
11. Lu, K. and Campisi, J. (1992). Ras proteins are essential and selective for the actionof insulin-like growth factor-1 late in the G1 phase of the cell cycle in Balb/c murine fibroblasts. Proc. Natl. Acad. Sci. (U.S.A.), 89, 3889-3893.
12. Egan, S. E. and Weinberg, R. A. (1993). The pathway to signal achievement. Nature, 365, 781-783.
13. ras. J. Biol. Chem., 269, 5699-5704.
14. White, M. F. and Kahn, C. R. (1994). The insulin signalling system. J. Biol. Chem., 269, 1-4.
15. Baltensperger, K., Kozma, L. M., Chemiack, A. D., Klarlund, J. K., Chawla, A., Banerjee, U. and Czech, M. P. (1993). Binding of the Ras activator son-of-sevenless to insulin receptor substrate-1 signalling complexes. Science, 260, 1950-1955.
16. Momomura, K., Toe, K., Seyama, Y., Takaku, F. and Kasuga, M. (1988). Insulin-induced tyrosine-phosphorylation in intact rat adipocytes. Biochem. Biophys. Res. Commun., 155, 1181-1186.
17. Skolnik, E. Y., Lee, C.-H., Batzer, A., Vicentini, L. M., Zhou, M., Daly, R., Myers, M. J. Jr., Backer, J. M., Ullrich, A., White, M. F. and Schlessinger, J. (1993). The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS-1 and She: implications for insulin control of ras signaling. EMBO J., 12, 1929-1936.
18. Myers, M. G., Backer, J. M., Sun, X. J., Shoelson, S., Hu, P., Shclessinger, J., Yoakim, M., Schaffhausen, B. and White, M. F. (1922). IRS-1 activates phosphatidylinositol 3′-kinase by associating with src homology domains of p85. Proc. Natl. Acad. Sci. (U.S.A.), 89, 10350-10354.
19. Lowenstein, E. J., Daly, R. J., Batzer, A. G., Li, W., Margolis, B., Lammers, R., Ullrich, A., Skolnik, E. Y., Bar-Sagi, D. and Schlessinger, J. (1992). The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell, 70, 431-442.
20. Li, N., Batzer, A., Daly, R., Yajnik, V., Skolnik, E., Chardin P., Bar-Sagi, B. Margolis, B. and Schlessinger, J. (1993). Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature, 363, 85-88.
21. Nishida, E. and Gotoh, Y. (1993). The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci., 18, 128-131.
22. ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature, 364, 308-312.
23. Dent, P., Lavoinne, A., Nakielny, S., Caudwell, F. B., Watt, P. and Cohen, P. (1990). The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature, 348, 302-308.
24. Hubbard, M. J. and Cohen, P. (1994). On target with a new mechanism for the regulation of protein phosphorylation. Trends Biochem. Sci., 18 (5), 172-177.
25. Hipskind, R. A., Buscher, D., Nordheim, A. and Baccarini, M. (1994). Ras/MAP kinase-dependent and independent signaling pathways target distinct ternary complex factors. Genes Dev., 8, 1803-1816.
26. Blumer, K. J., Johnson, G. L. and Lange-Carter, C. A. (1994). Mammalian mitogen-activated protein kinase kinase kinase (MEKK) can function in a yeast mitogen-activated protein kinase pathway downstream of protein kinase C. Proc. Natl. Acad. Sci (U.S.A.), 91, 4925-4929.
27. Giorgino, F., Almafhfouz, A., Goodyear, L. J. and Smith, R. J. (1993). Clucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J. Clin. Invest., 91, 2020-2030.
28. Saad, M. J., Folli,F., Kahn, J. A. and Kahn, C. R. (1993). Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J. Clin. Invest., 92, 2065-2072.
29. Turnbow, M. A., Keller, S. R., Rice, K. M. and Gamer, G. W. (1994). Dexamethasone down-regulation of insulin receptor substrate-1 in 3T3-L1 adipocytes. J. Biol. Chem., 269, 2516-2520.
30. Araki, E., Lipes, M. A., Patti, M. E., Bruning, J. C., Haag, B., Johnson, R. S. and Kahn, C. R. (1994). Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature, 372, 186-190.
31. Tanti, J.-F., Grémeaux, T., Van Obberghen, E. and Le Marchand-Brustel, Y. (1994). Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J. Biol. Chem., 269, 6051-6057.
32. Tanasijevic, M. J., Myers, M. G., Thoma, R. S. Crimmins, D. L., White, M. F. and Sacks, D. B. (1993). Phosphorylation of the insulin receptor substrate IRS-1 by casein kinase II. J. Biol. Chem., 268 (24), 18157-18166.
33. Yonezawa, K., Ueda, H., Hara, K., Nishida, K., Ando, A., Chavanieu, A., Matsuba, H., Shii, K., Yokono, K., Fukui, T., Calas, B., Grigorescu, F., Dhand, R., Gout, I., Otsu, M., Waterfield, M. D. and Kasuga, M. (1992). Insulin-dependent formation of a complex containing an 85kDa-subunit of phosphatidyl 3-kinase and tyrosine-phosphorylated insulin receptor substrate 1. J. Biol. Chem., 267, 25958-25966.
34. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randal, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
35. Ahn, N. G., Weiel, J. E., Chan, C. P. and Krebs, E. G. (1990). Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells. J. Biol. Chem., 265, 11487-11494.
36. Hansson, A. (1991). Protein kinase C-dependent activation of a myelin basic protein kinase by gastrin-releasing peptide in Swiss 3T3 fibroblasts. Cell Signalling, 3, 293-298.
37. Moody, A. J., Stan, M. A., Stan, M. and Gliemann, J. (1974). A simple free fat cell bioassay for insulin, Horm. Metab. Res., 6, 12-16.
38. Baldwin, D., Jr, Terris, S. and Steiner, D. F. (1980). Characterization of insulin-like actions of anti-insulin receptor antibodies. J Biol. Chem., 255, 4028-4034.
39. Cory, A. H., Owen, T. C., Barltrop, J. A. and Cory, J. G. (1991). Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Comm., 3, 207-212.
40. Hansson, A. and Thorẽn, M. (1995). Activation of MAP kinase in Swiss 3T3 fibroblasts by insulin-like growth factor-I. Growth Regulation, 5, 92-100.
41. Eldar-Finkelman, H., Seger, R., Vandenheede, J. R. and Krebs, E. G. (1995). Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells. J. Biol. Chem., 270, 987-990.
42. Shepherd, P. R., Navé, B. T. and Siddle, K. (1995). Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapa mycin in 3T3-L1 adipocytes: evidence for the involvement of phospoinositide 3-kinase and p70 ribosomal protein-S6 kinase. Biochem. J., 305, 25-28.
43. Ballou, L. M., Luther, H. and Thomas, G. (1991). MAP2 kinase and 70k S6 kinase He on distinct signalling pathways. Nature, 349, 348-350.
44. Blenis, J., Chung, J., Erikson, E., Alcorta, D. A. and Erikson, R. L. (1991). Distinct mechanisms for the activation of the Rsk kinases/MAP kinase/pp90rsk and pp70 kinase signaling system are indicated by inhibition of protein synthesis. Cell. Growth Differ. 2, 279-285.
45. Pelech, S. L., Sanghera, S. S., Paddon, H. B., Quayle, K. A. and Brownsey, R. W. (1991). Identification of a major maturation-activated acetyl-CoA-carboxylase kinase in sea star oocytes as p44mpk. Biochem. J., 274, 759-767.
46. Rice, K. M., Lienhard, G. E. and Garner, C. W. (1992). Regulation of the expression of pp160, a putative insulin receptor signal protein, by insulin, dexamethasone, and 1-methyl-3-isobutylxanthine in 3T3-L1 adipocytes. J. Biol. Chem., 267, 10163-10167.
47. Salcini, A. E., McGlade, J., Pelicci, G., Nicoletti, I., Pawson, T. and Pelicci, P. G. (1994). Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogens, 9, 2827-2836.
48. ras-GTP without detectable interaction of insulin receptor substrate 1 (IRS1) with Grb2. J. Biol. Chem., 269, 33116-33122.
49. Sasaoka, T., Rose, D. W., Jhun, B. H., Saltiel, A. R., Draznin, B. and Olefsky, J. M. (1994) Evidence for a functional role of She proteins in mitoge is signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J. Biol. Chem., 269, 13689-13694.
50. Smit, L., de Vries-Smits, A. M., Bos, J. L. and Borst, J. (1994). B cell antigen receptor stimulation induces formation of a Shc Grb2 complex containing multiple tyrosine-phosphorylated proteins. J. Biol. Chem., 269, 20209-20212.
51. Gotoh, N., Tojo, A., Muroya, K., Hashimoto, Y., Hattori, S., Nakamura, S., Takenawa, T., Yazaki, Y. and Shibuya, M. (1994). Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of She protein and Shc-Grb2/ash association and retains mitogenic activity. Proc. Natl. Acad. Sci. (U.S.A.), 91, 167-171.
52. Soler, C., Alvarez, C. V., Beguinot, L. and Carpenter, G. (1994). Potent Shc tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites. Oncogens, 9, 2207-2215.
53. Yamauchi, K. and Pessin, J. E. (1994). Insulin receptor sub-strate-1 (IRS1) and She compete for a limited pool of Grb2 in mediating insulin downstream signalling. J. Biol. Chem., 269, 31107-31114.
54. ras-GTP formation. J. Biol. Chem., 269, 10734-10738.
55. Milarski, K. L. and Saltiel, A. R. (1994). Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J. Biol. Chem., 269, 21239-21243.
56. Beitner-Johnson, D. and LeRoith, D. (1995). Insulin-like growth factor-I stimulates tyrosine phosphorylation of endogenous c-Crk. J. Biol. Chem., 270, 5187-5190.
57. Levy-Tolendano, R., Taouis, M., Blaettler, D. H., Gorden, P. and Taylor, S. I. (1994), Insulin-indiced activation of phosphatidyl inositol 3-kinase. J. Biol. Chem., 269, 31178-31182.
58. Yamamoto, K., Altschuler, D., Wood, E., Horlick, K. Jacobs, S. and Lapetina, E. G. (1992). Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85. J. Biol. Chem., 267, 11337-11343.